Bönig, H., Verbeek, M., Herhaus, P., Braitsch, K., Beutel, G., Schmid, C., . . . Bader, P. (2023). Real-world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC-FFM in ruxolitinib-refractory acute graft-versus-host disease. Journal of translational medicine, 21, . https://doi.org/10.1186/s12967-023-04731-1
Chicago-Zitierstil (17. Ausg.)Bönig, Halvard, et al. "Real-world Data Suggest Effectiveness of the Allogeneic Mesenchymal Stromal Cells Preparation MSC-FFM in Ruxolitinib-refractory Acute Graft-versus-host Disease." Journal of Translational Medicine 21 (2023). https://doi.org/10.1186/s12967-023-04731-1.
MLA-Zitierstil (9. Ausg.)Bönig, Halvard, et al. "Real-world Data Suggest Effectiveness of the Allogeneic Mesenchymal Stromal Cells Preparation MSC-FFM in Ruxolitinib-refractory Acute Graft-versus-host Disease." Journal of Translational Medicine, vol. 21, 2023, https://doi.org/10.1186/s12967-023-04731-1.